Development and Physical Characterization of Injectable Nanocrystals Derived from Euphorbia Fractiflexa Stem SAP and Antibacterial Efficacy
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study explores Euphorbia fractiflexa (E. fractiflexa) for pharmaceutical nanotechnology, developing plant-derived nanocrystals (NCs) with antibacterial properties. These sustainable NCs show potential for drug delivery, though further optimization is needed for enhanced efficacy.
Area Of Science
- Nanotechnology
- Pharmaceutical Sciences
- Materials Science
Background
- Euphorbia fractiflexa (E. fractiflexa), a desert plant, is underexplored for pharmaceutical applications.
- Plant-derived nanoparticles, particularly nanocrystals (NCs), offer potential for improved drug delivery and combating antibiotic resistance.
- E. fractiflexa's natural abundance and sustainability in arid climates present a viable green resource for NC development.
Purpose Of The Study
- To investigate the pharmaceutical potential of E. fractiflexa stem sap for producing nanocrystals (NCs).
- To evaluate the physicochemical properties and antibacterial activity of E. fractiflexa-derived NCs.
- To explore the utility of E. fractiflexa as a source for novel nanomedicine formulations.
Main Methods
- Collected milky stem sap from E. fractiflexa for NC production.
- Characterized NCs using dynamic light scattering (DLS) for zeta potential, particle size, and PDI.
- Analyzed NC morphology via scanning electron microscopy (SEM) and evaluated antibacterial activity using the agar well diffusion method against bacterial strains, with ciprofloxacin as a reference.
Main Results
- E. fractiflexa-derived NCs exhibited moderate stability (zeta potential: -7.62 ± 8.83 mV) and particle sizes of 100-200 nm, suitable for injectables.
- SEM revealed irregular, inhomogeneous crystal structures.
- NCs demonstrated significant antibacterial activity against Gram-positive and Gram-negative bacteria (inhibition zones: 18-21.3 µm), though slightly less effective than ciprofloxacin.
Conclusions
- E. fractiflexa is a valuable natural resource for developing innovative nanotechnology formulations.
- The prepared NCs possess significant antibacterial activity and suitable physicochemical properties for injectable drug delivery systems.
- Further formulation optimization is required to enhance the antibacterial efficacy of E. fractiflexa-derived NCs for future applications.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.